BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 17194620)

  • 1. Allele and genotype frequencies of metabolic genes in Native Americans from Argentina and Paraguay.
    Bailliet G; Santos MR; Alfaro EL; Dipierri JE; Demarchi DA; Carnese FR; Bianchi NO
    Mutat Res; 2007 Mar; 627(2):171-7. PubMed ID: 17194620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CYP1A1, CYP2D6, CYP2E1, NAT2, GSTM1 and GSTT1 polymorphisms or their combinations are associated with the increased risk of the laryngeal squamous cell carcinoma.
    Gajecka M; Rydzanicz M; Jaskula-Sztul R; Kujawski M; Szyfter W; Szyfter K
    Mutat Res; 2005 Jul; 574(1-2):112-23. PubMed ID: 15914211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genotype and allele frequencies of N-acetyltransferase 2 and glutathione S-transferase in the Iranian population.
    Torkaman-Boutorabi A; Hoormand M; Naghdi N; Bakhshayesh M; Milanian I
    Clin Exp Pharmacol Physiol; 2007 Nov; 34(11):1207-11. PubMed ID: 17880378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of CYP2D6, CYP1A1, CYP2E1, GSTT1, and GSTM1 genes in the susceptibility to acute leukemias.
    Aydin-Sayitoglu M; Hatirnaz O; Erensoy N; Ozbek U
    Am J Hematol; 2006 Mar; 81(3):162-70. PubMed ID: 16493615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Genetic polymorphism in GST, NAT2, and MTRR and susceptibility to childhood acute leukemia].
    Gra OA; Glotov AS; Kozhekbaeva Zhm; Makarova OV; Nasedkina TV
    Mol Biol (Mosk); 2008; 42(2):214-25. PubMed ID: 18610829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Candidate genetic modifiers of individual susceptibility to renal cell carcinoma: a study of polymorphic human xenobiotic-metabolizing enzymes.
    Longuemaux S; Deloménie C; Gallou C; Méjean A; Vincent-Viry M; Bouvier R; Droz D; Krishnamoorthy R; Galteau MM; Junien C; Béroud C; Dupret JM
    Cancer Res; 1999 Jun; 59(12):2903-8. PubMed ID: 10383153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CYP2D6 genotype and phenotype in Amerindians of Tepehuano origin and Mestizos of Durango, Mexico.
    Sosa-Macías M; Elizondo G; Flores-Pérez C; Flores-Pérez J; Bradley-Alvarez F; Alanis-Bañuelos RE; Lares-Asseff I
    J Clin Pharmacol; 2006 May; 46(5):527-36. PubMed ID: 16638736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymorphism in cytochrome P450 CYP2D6, CYP1A1, CYP2E1 and glutathione S-transferase, GSTM1, GSTM3, GSTT1 and susceptibility to tobacco-related cancers: studies in upper aerodigestive tract cancers.
    Matthias C; Bockmühl U; Jahnke V; Jones PW; Hayes JD; Alldersea J; Gilford J; Bailey L; Bath J; Worrall SF; Hand P; Fryer AA; Strange RC
    Pharmacogenetics; 1998 Apr; 8(2):91-100. PubMed ID: 10022746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of cytochrome P450, glutathione S-transferase and N-acetyl transferase 2 gene polymorphisms with incidence of acute myeloid leukemia.
    Majumdar S; Mondal BC; Ghosh M; Dey S; Mukhopadhyay A; Chandra S; Dasgupta UB
    Eur J Cancer Prev; 2008 Apr; 17(2):125-32. PubMed ID: 18287869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of glutathione S-transferase M1 and glutathione S-transferase T1 gene polymorphisms suggests age-related relationships in a northern Italian population.
    Santovito A; Cervella P; Burgarello C; Bigatti MP; Sella G; Delpero M
    Arch Toxicol; 2008 Dec; 82(12):903-7. PubMed ID: 18491076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic polymorphisms of metabolic enzymes CYP1A1, CYP2D6, GSTM1 and GSTT1 and leukemia susceptibility.
    Chen HC; Hu WX; Liu QX; Li WK; Chen FZ; Rao ZZ; Liu XF; Luo YP; Cao YF
    Eur J Cancer Prev; 2008 Jun; 17(3):251-8. PubMed ID: 18414197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CYP2D6 genetic polymorphisms are associated with susceptibility to pituitary tumors.
    Gomes L; Lemos MC; Paiva I; Ribeiro C; Carvalheiro M; Regateiro FJ
    Acta Med Port; 2005; 18(5):339-43. PubMed ID: 16611538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Analysis of the polymorphic alleles of genes encoding phase 1 and phase 2 detoxication enzymes in patients with endometriosis].
    Ivashchenko TE; Shved NIu; Kramareva NA; Aĭlamazian EK; Baranov VS
    Genetika; 2003 Apr; 39(4):525-9. PubMed ID: 12760253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genotype frequencies of polymorphic GSTM1, GSTT1, and cytochrome P450 CYP1A1 in Mexicans.
    Montero R; Araujo A; Carranza P; Mejía-Loza V; Serrano L; Albores A; Salinas JE; Camacho-Carranza R
    Hum Biol; 2007 Jun; 79(3):299-312. PubMed ID: 18078203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of the CYP2D6 gene mutations and their consequences for enzyme function in a West African population.
    Griese EU; Asante-Poku S; Ofori-Adjei D; Mikus G; Eichelbaum M
    Pharmacogenetics; 1999 Dec; 9(6):715-23. PubMed ID: 10634134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glutathione S-transferase T1 (GSTT1) and M1 (GSTM1) polymorphisms in a sample of the population in Northern Italy.
    Bigatti MP; Santovito A
    Genetika; 2007 Jun; 43(6):827-30. PubMed ID: 17853809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arylamine N-acetyltransferase 1 (NAT1) and 2 (NAT2) polymorphisms in susceptibility to bladder cancer: the influence of smoking.
    Okkels H; Sigsgaard T; Wolf H; Autrup H
    Cancer Epidemiol Biomarkers Prev; 1997 Apr; 6(4):225-31. PubMed ID: 9107426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Detoxication gene polymorphism and susceptibility to sporadic motor neuron disease in Russian population].
    Skvortsova VI; Slominskiĭ PA; Shadrina MI; Levitskiĭ GN; Levitskaia NI; Alekhin AV; Zherebtsova AL; Serdiuk AV; Limborskaia SA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2006; 106(1):4-13. PubMed ID: 16459354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. No association between genetic polymorphisms of CYP1A1, GSTM1, GSTT1, GSTP1, NAT2, and nasopharyngeal carcinoma in Taiwan.
    Cheng YJ; Chien YC; Hildesheim A; Hsu MM; Chen IH; Chuang J; Chang J; Ma YD; Luo CT; Hsu WL; Hsu HH; Huang H; Chang JF; Chen CJ; Yang CS
    Cancer Epidemiol Biomarkers Prev; 2003 Feb; 12(2):179-80. PubMed ID: 12582034
    [No Abstract]   [Full Text] [Related]  

  • 20. Lack of association between human longevity and genetic polymorphisms in drug-metabolizing enzymes at the NAT2, GSTM1 and CYP2D6 loci.
    Muiras ML; Verasdonck P; Cottet F; Schächter F
    Hum Genet; 1998 May; 102(5):526-32. PubMed ID: 9654200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.